^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    MT-026

    i
    Other names: MT-026, IL-13Rα2 UCAR-T cell therapy
    Associations

    News

    Trials
    Company:
    Suzhou Maximum Bio-tech
    Drug class:
    IL-13Rα2-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    over1year
    Safety and Efficacy of Targeted IL-13 Rα2 or B7-H3 UCAR-T for Advanced Glioma (clinicaltrials.gov)
    P=N/A, N=12, Recruiting, Second Affiliated Hospital of Soochow University
    New trial • CAR T-Cell Therapy • Metastases
    |
    PD-L1 (Programmed death ligand 1) • CD276 (CD276 Molecule)
    |
    MT-026 • MT027